Kathrin Ungethüm

• [ 2024 ]
• [ 2023 ]
• [ 2022 ]
• [ 2021 ]

• 1.

  Vollmuth C, Fiessler C, Montellano FA, Kollikowski AM, Essig F, Oeckl P, et al. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke. Eur Stroke J. 2024;:23969873241234436.
  • [ DOI ]
• 1.

  Montellano FA, Rücker V, Ungethüm K, Penalba A, Hotter B, Giralt M, et al. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies. Eur Stroke J. 2024;:23969873241250272.
  • [ DOI ]

• 1.

  Ungethüm K, Wiedmann S, Wagner M, Leyh R, Ertl G, Frantz S, et al. Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys. Clin Res Cardiol. 2023;112(2):285-98.
  • [ DOI ]
• 1.

  Hebestreit H, Lapstich AM, Brandstetter L, Krauth C, Deckert J, Haas K, et al. Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. EClinicalMedicine. 2023;65:102260.
  • [ DOI ]

• 1.

  Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190.
  • [ DOI ]
• 1.

  Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, et al. Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1):47. Available from: https://doi.org/10.1186/s13023-022-02176-1
  • [ DOI ]
• 1.

  Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, et al. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries. Nature [Internet]. 2022;612(7938):E7-E7. Available from: https://doi.org/10.1038/s41586-022-05492-5
  • [ DOI ]
• 1.

  Montellano FA, Kluter EJ, Rücker V, Ungethüm K, Mackenrodt D, Wiedmann S, et al. Cardiac dysfunction and high-sensitive C-reactive protein are associated with troponin T elevation in ischemic stroke: insights from the SICFAIL study. BMC Neurology [Internet]. 2022;22(1):511. Available from: https://doi.org/10.1186/s12883-022-03017-1
  • [ DOI ]
• 1.

  Schons M, Pilgram L, Reese JP, Stecher M, Anton G, Appel KS, et al. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37(8):849-70.
  • [ DOI ]

• 1.

  Seyhan M, Ungethüm K, Schuhmann MK, Mackenrodt D, Rücker V, Montellano FA, et al. Feasibility of platelet marker analysis in ischemic stroke patients and their association with one-year outcome. A pilot project within a subsample of the Stroke Induced Cardiac Failure in Mice and Men (SICFAIL) cohort study. Platelets [Internet]. 2021;33(5):772-80. Available from: https://doi.org/10.1080/09537104.2021.2002834
  • [ DOI ]
• 1.

  Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • [ DOI ]
• 1.

  Montellano FA, Ungethüm K, Ramiro L, Nacu A, Hellwig S, Fluri F, et al. Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review. Stroke. 2021;52(2):543-51.
  • [ DOI ]
• 1.

  Heuschmann PU, Montellano FA, Ungethüm K, Rücker V, Wiedmann S, Mackenrodt D, et al. Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study. ESC Heart Failure [Internet]. 2021;8(2):1117-29. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13145
  • [ DOI ]